Table 4.
Risk factors for mortality (death within 30 days after TAE)
| Univariate analysis | |||
| Variable | Success | Failure | p value |
| Cases included in analysis = 309 | 81.6% (252) | 18.4% (57) | |
| Age in yearsa | 62.2 ± 16.0 | 65.8 ± 14.4 | 0.128 |
| Sex (male) | 65.5% (195/252) | 59.6% (34/57) | 0.407 |
| ≥2 concomitant diseases | 38.8% (97/250) | 50.0% (28/56) | 0.123 |
| Hb level in mmol l–1a | 5.8 ± 1.3 | 5.4 ± 1.3 | *0.045 |
| FFPa | 0.2 ± 1.2 | 0.2 ± 1.3 | 0.274 |
| Red blood cell concentratesa | 2.2 ± 5.0 | 3.8 ± 8.7 | 0.374 |
| ≥6 units of red blood cell concentrates | 11.3% (28/247) | 21.4% (12/56) | *0.045 |
| No bleeding evidence (CT) | 23.8% (36/151) | 16.2% (6/37) | 0.318 |
| No bleeding evidence (DSA) | 2.4% (6/252) | 1.8% (1/57) | 0.774 |
| TAE during off-hours including weekend | 48.8% (123/252) | 59.6% (34/57) | 0.139 |
| Selective catheterization only | 20.6% (52/252) | 19.3% (11/57) | 0.821 |
| Sole use of coils for embolization | 54.0% (136/252) | 47.4% (27/57) | 0.367 |
| >1 vessel embolized | 13.1% (33/252) | 19.3% (11/57) | 0.226 |
| Anticoagulation | 30.0% (75/250) | 37.5% (21/56) | 0.274 |
| Corticosteroids | 7.6% (19/250) | 1.8% (1/56) | 0.112 |
| Shock | 13.1% (33/251) | 35.7% (20/56) | *<0.001 |
| Coagulopathy | 14.3% (32/223) | 33.3% (16/48) | *0.002 |
| Referral from other hospital | 15.9% (40/252) | 14.3% (8/56) | 0.767 |
| Referral from ICU | 28.8% (72/250) | 35.7% (20/56) | 0.308 |
| Clinical success/recurrent bleeding | 15.1% (36/239) | 48.0% (24/50) | *<0.001 |
| Multivariate analysis | |||